Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing...
According to reports from the Korean Herald, the government of Korea will spend 2.93 trillion won (US$2.61 billion...
ROKIT Healthcare, Inc., a regenerative medicine company focused on the development of novel regenerative therapeutic str...
SK Biopharmaceuticals and Arvelle Therapeutics GmbH have announced that they have entered into an exclusive licensing ag...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the...
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...
Samsung Bioepis has announced that the U.S. Food and Drug Administration has approved ONTRUZANT, a biosimilar referencin...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...
Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, has announced that its Suisse su...
NORGINE B.V. (Norgine), a leading European specialty pharmaceutical company and KOREA PHARMA CO., LTD. (Korea Pharma), a...
Gilead Sciences, Inc. and Yuhan Corporation has announced that the companies have entered into a licensing and collabora...
South Korea is the 27th largest country worldwide with 51.2 million people as of 2017. In their healthcare market, ...
Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that t...
In recent years, several regulatory laws enforcing data privacy – that requires organizations to strengthen data p...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a licen...
Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. have announced that the U.S. Food and Drug Administration (FDA) ...
Prestige BioPharma (“Prestige”) has reached a licensing agreement with Cipla Limited (“Cipla&rdqu...
UK-based Avacta Group plc , the developer of Affimer biotherapeutics and reagents and Korea's LG Chem Life Science...
